129 related articles for article (PubMed ID: 23394726)
21. Vaccine epidemiology: Its role in promoting sound immunization programs in Japan.
Hirota Y; Ozasa K; Nakano T
Vaccine; 2017 Aug; 35(36):4787-4790. PubMed ID: 28818469
[TBL] [Abstract][Full Text] [Related]
22. Enhancing access to immunization services and exploiting the benefits of recent innovations in the African region.
Okeibunor JC; Akanmori BD; Balcha GM; Mihigo R; Vaz RM; Nshimirimana D
Vaccine; 2013 Aug; 31(37):3772-6. PubMed ID: 23800541
[TBL] [Abstract][Full Text] [Related]
23. Vaccine innovations for emerging infectious diseases-a symposium report.
Cable J; Srikantiah P; Crowe JE; Pulendran B; Hill A; Ginsberg A; Koff W; Mathew A; Ng T; Jansen K; Glenn G; Permar S; Wilson I; Weiner DB; Weissman D; Rappuoli R
Ann N Y Acad Sci; 2020 Feb; 1462(1):14-26. PubMed ID: 31659752
[TBL] [Abstract][Full Text] [Related]
24. Report of the 2nd "French Clinical Vaccinology Meeting Jean-Gerard Guillet": immunization and respiratory diseases.
Loulergue P; Burgel PR; Carrat F; Fritzell B; Guthmann JP; Locht C; Power UF; Varon E; Dusser D; Launay O
Vaccine; 2010 Sep; 28(40):6551-5. PubMed ID: 20674881
[TBL] [Abstract][Full Text] [Related]
25. NIAID meeting report: improving malaria vaccine strategies through the application of immunological principles.
Mo AX; Augustine AD
Vaccine; 2014 Feb; 32(10):1132-8. PubMed ID: 24060568
[TBL] [Abstract][Full Text] [Related]
26. Vaccine adjuvants: a priority for vaccine research.
Harandi AM; Medaglini D; Shattock RJ;
Vaccine; 2010 Mar; 28(12):2363-6. PubMed ID: 20064476
[TBL] [Abstract][Full Text] [Related]
27. Influenza vaccination in the Americas: Progress and challenges after the 2009 A(H1N1) influenza pandemic.
Ropero-Álvarez AM; El Omeiri N; Kurtis HJ; Danovaro-Holliday MC; Ruiz-Matus C
Hum Vaccin Immunother; 2016 Aug; 12(8):2206-2214. PubMed ID: 27196006
[TBL] [Abstract][Full Text] [Related]
28. The Children's Vaccine Initiative.
Caddell A
Afr Health; 1997 Nov; 20(1):15. PubMed ID: 12348372
[TBL] [Abstract][Full Text] [Related]
29. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
Leroux-Roels G
Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254
[TBL] [Abstract][Full Text] [Related]
30. Selected papers from the Fourth Annual q-bio Conference on Cellular Information Processing.
Nemenman I; Faeder JR; Hlavacek WS; Jiang Y; Wall ME; Zilman A
Phys Biol; 2011 Oct; 8(5):050301. PubMed ID: 21832800
[TBL] [Abstract][Full Text] [Related]
31. First International Precision Vaccines Conference: Multidisciplinary Approaches to Next-Generation Vaccines.
Borriello F; van Haren SD; Levy O
mSphere; 2018 Aug; 3(4):. PubMed ID: 30068557
[TBL] [Abstract][Full Text] [Related]
32. [Current events in vaccination].
Aubert M; Aumaître H; Beytout J; Bloch K; Bouhour D; Callamand P; Chave C; Cheymol J; Combadière B; Dahlab A; Denis F; De Pontual L; Dodet B; Dommergues MA; Dufour V; Gagneur A; Gaillat J; Gaudelus J; Gavazzi G; Gillet Y; Gras-le-Guen C; Haas H; Hanslik T; Hau-Rainsard I; Larnaudie S; Launay O; Lorrot M; Loulergue P; Malvy D; Marchand S; Picherot G; Pinquier D; Pulcini C; Rabaud C; Regnier F; Reinert P; Sana C; Savagner C; Soubeyrand B; Stephan JL; Strady C
Arch Pediatr; 2011 Nov; 18(11):1234-46. PubMed ID: 22019286
[TBL] [Abstract][Full Text] [Related]
33. Remarks spoken before the audience at the final conference plenary session, entitled: "Future directions," at the International Conference on Advances in AIDS Vaccine Development. Fourth annual meeting of the National Cooperative Vaccine Development Groups for AIDS.
Nzila N
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1521-2. PubMed ID: 1466995
[TBL] [Abstract][Full Text] [Related]
34. WHO informal consultation on quality, safety and efficacy specifications for live attenuated rotavirus vaccines Mexico City, Mexico, 8-9 February 2005.
Wood D;
Vaccine; 2005 Dec; 23(48-49):5478-87. PubMed ID: 16129525
[TBL] [Abstract][Full Text] [Related]
35. [Research progress and prospect of universal influenza vaccine].
Luo DY; Xue CY; Cao YC
Bing Du Xue Bao; 2013 Nov; 29(6):646-50. PubMed ID: 24520771
[TBL] [Abstract][Full Text] [Related]
36. Systems Biology-Based Platforms to Accelerate Research of Emerging Infectious Diseases.
Oh SJ; Choi YK; Shin OS
Yonsei Med J; 2018 Mar; 59(2):176-186. PubMed ID: 29436184
[TBL] [Abstract][Full Text] [Related]
37. Towards Precision Vaccines: Lessons From the Second International Precision Vaccines Conference.
Soni D; Van Haren SD; Idoko OT; Evans JT; Diray-Arce J; Dowling DJ; Levy O
Front Immunol; 2020; 11():590373. PubMed ID: 33178222
[TBL] [Abstract][Full Text] [Related]
38. Use of the Microparticle Nanoscale Silicon Dioxide as an Adjuvant To Boost Vaccine Immune Responses against Influenza Virus in Neonatal Mice.
Russell RF; McDonald JU; Lambert L; Tregoning JS
J Virol; 2016 May; 90(9):4735-4744. PubMed ID: 26912628
[TBL] [Abstract][Full Text] [Related]
39. Novel vaccines: bridging research, development and production.
Demirjian A; Levy O
Expert Rev Vaccines; 2008 Nov; 7(9):1321-4. PubMed ID: 18980535
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
